IBDEI1S4 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31796,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,31797,0)
 ;;=D03.9^^190^1943^155
 ;;^UTILITY(U,$J,358.3,31797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31797,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,31797,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,31797,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,31798,0)
 ;;=C45.0^^190^1943^156
 ;;^UTILITY(U,$J,358.3,31798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31798,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,31798,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,31798,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,31799,0)
 ;;=C90.01^^190^1943^157
 ;;^UTILITY(U,$J,358.3,31799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31799,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,31799,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,31799,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,31800,0)
 ;;=C90.00^^190^1943^158
 ;;^UTILITY(U,$J,358.3,31800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31800,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,31800,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,31800,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,31801,0)
 ;;=C94.6^^190^1943^159
 ;;^UTILITY(U,$J,358.3,31801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31801,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,31801,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,31801,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,31802,0)
 ;;=D61.82^^190^1943^160
 ;;^UTILITY(U,$J,358.3,31802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31802,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,31802,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,31802,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,31803,0)
 ;;=D47.9^^190^1943^161
 ;;^UTILITY(U,$J,358.3,31803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31803,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,31803,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,31803,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,31804,0)
 ;;=D53.9^^190^1943^165
 ;;^UTILITY(U,$J,358.3,31804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31804,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,31804,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,31804,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,31805,0)
 ;;=D47.4^^190^1943^166
 ;;^UTILITY(U,$J,358.3,31805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31805,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,31805,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,31805,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,31806,0)
 ;;=D59.1^^190^1943^25
 ;;^UTILITY(U,$J,358.3,31806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31806,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,31806,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,31806,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,31807,0)
 ;;=D51.3^^190^1943^180
 ;;^UTILITY(U,$J,358.3,31807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31807,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,31807,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,31807,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,31808,0)
 ;;=D77.^^190^1943^52
 ;;^UTILITY(U,$J,358.3,31808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31808,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,31808,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,31808,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,31809,0)
 ;;=D58.2^^190^1943^78
 ;;^UTILITY(U,$J,358.3,31809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31809,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,31809,1,4,0)
 ;;=4^D58.2
